Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Essential Oils Plant Extracts Livestock Market

ID: MRFR/Agri/6564-HCR
90 Pages
Snehal Singh
Last Updated: April 06, 2026
Essential Oils and Plant Extracts for Livestock Market Size, Share, Industry Trend & Analysis Research Report Information By Type (Essential Oils, Plant Extracts), By Form (Solid/Powder, Liquid), By Livestock (Livestock, Swine, Poultry, Ruminants, Aquaculture, Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Forecast Till 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Type (USD Billion)
      1. 4.1.1 Essential Oils
      2. 4.1.2 Plant Extracts
    2. 4.2 Pharmaceutical, BY Form (USD Billion)
      1. 4.2.1 Solid/Powder
      2. 4.2.2 Liquid
    3. 4.3 Pharmaceutical, BY Livestock (USD Billion)
      1. 4.3.1 Livestock
      2. 4.3.2 Swine
      3. 4.3.3 Poultry
      4. 4.3.4 Ruminants
      5. 4.3.5 Aquaculture
      6. 4.3.6 Others
    4. 4.4 Pharmaceutical, BY Region (USD Billion)
      1. 4.4.1 North America
        1. 4.4.1.1 US
        2. 4.4.1.2 Canada
      2. 4.4.2 Europe
        1. 4.4.2.1 Germany
        2. 4.4.2.2 UK
        3. 4.4.2.3 France
        4. 4.4.2.4 Russia
        5. 4.4.2.5 Italy
        6. 4.4.2.6 Spain
        7. 4.4.2.7 Rest of Europe
      3. 4.4.3 APAC
        1. 4.4.3.1 China
        2. 4.4.3.2 India
        3. 4.4.3.3 Japan
        4. 4.4.3.4 South Korea
        5. 4.4.3.5 Malaysia
        6. 4.4.3.6 Thailand
        7. 4.4.3.7 Indonesia
        8. 4.4.3.8 Rest of APAC
      4. 4.4.4 South America
        1. 4.4.4.1 Brazil
        2. 4.4.4.2 Mexico
        3. 4.4.4.3 Argentina
        4. 4.4.4.4 Rest of South America
      5. 4.4.5 MEA
        1. 4.4.5.1 GCC Countries
        2. 4.4.5.2 South Africa
        3. 4.4.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Cargill (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 BASF (DE)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Döhler (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Kemin Industries (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Herbalife Nutrition Ltd. (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Givaudan (CH)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Symrise (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 International Flavors & Fragrances (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Naturex (FR)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY TYPE
    4. 6.4 US MARKET ANALYSIS BY FORM
    5. 6.5 US MARKET ANALYSIS BY LIVESTOCK
    6. 6.6 CANADA MARKET ANALYSIS BY TYPE
    7. 6.7 CANADA MARKET ANALYSIS BY FORM
    8. 6.8 CANADA MARKET ANALYSIS BY LIVESTOCK
    9. 6.9 EUROPE MARKET ANALYSIS
    10. 6.10 GERMANY MARKET ANALYSIS BY TYPE
    11. 6.11 GERMANY MARKET ANALYSIS BY FORM
    12. 6.12 GERMANY MARKET ANALYSIS BY LIVESTOCK
    13. 6.13 UK MARKET ANALYSIS BY TYPE
    14. 6.14 UK MARKET ANALYSIS BY FORM
    15. 6.15 UK MARKET ANALYSIS BY LIVESTOCK
    16. 6.16 FRANCE MARKET ANALYSIS BY TYPE
    17. 6.17 FRANCE MARKET ANALYSIS BY FORM
    18. 6.18 FRANCE MARKET ANALYSIS BY LIVESTOCK
    19. 6.19 RUSSIA MARKET ANALYSIS BY TYPE
    20. 6.20 RUSSIA MARKET ANALYSIS BY FORM
    21. 6.21 RUSSIA MARKET ANALYSIS BY LIVESTOCK
    22. 6.22 ITALY MARKET ANALYSIS BY TYPE
    23. 6.23 ITALY MARKET ANALYSIS BY FORM
    24. 6.24 ITALY MARKET ANALYSIS BY LIVESTOCK
    25. 6.25 SPAIN MARKET ANALYSIS BY TYPE
    26. 6.26 SPAIN MARKET ANALYSIS BY FORM
    27. 6.27 SPAIN MARKET ANALYSIS BY LIVESTOCK
    28. 6.28 REST OF EUROPE MARKET ANALYSIS BY TYPE
    29. 6.29 REST OF EUROPE MARKET ANALYSIS BY FORM
    30. 6.30 REST OF EUROPE MARKET ANALYSIS BY LIVESTOCK
    31. 6.31 APAC MARKET ANALYSIS
    32. 6.32 CHINA MARKET ANALYSIS BY TYPE
    33. 6.33 CHINA MARKET ANALYSIS BY FORM
    34. 6.34 CHINA MARKET ANALYSIS BY LIVESTOCK
    35. 6.35 INDIA MARKET ANALYSIS BY TYPE
    36. 6.36 INDIA MARKET ANALYSIS BY FORM
    37. 6.37 INDIA MARKET ANALYSIS BY LIVESTOCK
    38. 6.38 JAPAN MARKET ANALYSIS BY TYPE
    39. 6.39 JAPAN MARKET ANALYSIS BY FORM
    40. 6.40 JAPAN MARKET ANALYSIS BY LIVESTOCK
    41. 6.41 SOUTH KOREA MARKET ANALYSIS BY TYPE
    42. 6.42 SOUTH KOREA MARKET ANALYSIS BY FORM
    43. 6.43 SOUTH KOREA MARKET ANALYSIS BY LIVESTOCK
    44. 6.44 MALAYSIA MARKET ANALYSIS BY TYPE
    45. 6.45 MALAYSIA MARKET ANALYSIS BY FORM
    46. 6.46 MALAYSIA MARKET ANALYSIS BY LIVESTOCK
    47. 6.47 THAILAND MARKET ANALYSIS BY TYPE
    48. 6.48 THAILAND MARKET ANALYSIS BY FORM
    49. 6.49 THAILAND MARKET ANALYSIS BY LIVESTOCK
    50. 6.50 INDONESIA MARKET ANALYSIS BY TYPE
    51. 6.51 INDONESIA MARKET ANALYSIS BY FORM
    52. 6.52 INDONESIA MARKET ANALYSIS BY LIVESTOCK
    53. 6.53 REST OF APAC MARKET ANALYSIS BY TYPE
    54. 6.54 REST OF APAC MARKET ANALYSIS BY FORM
    55. 6.55 REST OF APAC MARKET ANALYSIS BY LIVESTOCK
    56. 6.56 SOUTH AMERICA MARKET ANALYSIS
    57. 6.57 BRAZIL MARKET ANALYSIS BY TYPE
    58. 6.58 BRAZIL MARKET ANALYSIS BY FORM
    59. 6.59 BRAZIL MARKET ANALYSIS BY LIVESTOCK
    60. 6.60 MEXICO MARKET ANALYSIS BY TYPE
    61. 6.61 MEXICO MARKET ANALYSIS BY FORM
    62. 6.62 MEXICO MARKET ANALYSIS BY LIVESTOCK
    63. 6.63 ARGENTINA MARKET ANALYSIS BY TYPE
    64. 6.64 ARGENTINA MARKET ANALYSIS BY FORM
    65. 6.65 ARGENTINA MARKET ANALYSIS BY LIVESTOCK
    66. 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
    67. 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORM
    68. 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY LIVESTOCK
    69. 6.69 MEA MARKET ANALYSIS
    70. 6.70 GCC COUNTRIES MARKET ANALYSIS BY TYPE
    71. 6.71 GCC COUNTRIES MARKET ANALYSIS BY FORM
    72. 6.72 GCC COUNTRIES MARKET ANALYSIS BY LIVESTOCK
    73. 6.73 SOUTH AFRICA MARKET ANALYSIS BY TYPE
    74. 6.74 SOUTH AFRICA MARKET ANALYSIS BY FORM
    75. 6.75 SOUTH AFRICA MARKET ANALYSIS BY LIVESTOCK
    76. 6.76 REST OF MEA MARKET ANALYSIS BY TYPE
    77. 6.77 REST OF MEA MARKET ANALYSIS BY FORM
    78. 6.78 REST OF MEA MARKET ANALYSIS BY LIVESTOCK
    79. 6.79 KEY BUYING CRITERIA OF PHARMACEUTICAL
    80. 6.80 RESEARCH PROCESS OF MRFR
    81. 6.81 DRO ANALYSIS OF PHARMACEUTICAL
    82. 6.82 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    83. 6.83 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    84. 6.84 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    85. 6.85 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
    86. 6.86 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Billion)
    87. 6.87 PHARMACEUTICAL, BY FORM, 2024 (% SHARE)
    88. 6.88 PHARMACEUTICAL, BY FORM, 2024 TO 2035 (USD Billion)
    89. 6.89 PHARMACEUTICAL, BY LIVESTOCK, 2024 (% SHARE)
    90. 6.90 PHARMACEUTICAL, BY LIVESTOCK, 2024 TO 2035 (USD Billion)
    91. 6.91 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.2.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.3.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.3.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.4.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.4.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.5.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.5.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.6.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.6.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.7.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.7.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.8.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.8.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.9.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.9.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.10.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.10.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.11.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.11.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.12.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.12.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.13.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.13.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.14.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.14.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.15.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.15.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.16.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.16.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.17.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.17.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.18.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.18.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.19.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.19.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.20.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.20.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.21.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.21.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.22.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.22.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.23.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.23.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.24.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.24.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.25.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.25.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.26.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.26.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.27.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.27.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.28.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.28.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.29.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.29.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.30.2 BY FORM, 2025-2035 (USD Billion)
      3. 7.30.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Pharmaceutical Market Segmentation

Pharmaceutical By Type (USD Billion, 2025-2035)

  • Essential Oils
  • Plant Extracts

Pharmaceutical By Form (USD Billion, 2025-2035)

  • Solid/Powder
  • Liquid

Pharmaceutical By Livestock (USD Billion, 2025-2035)

  • Livestock
  • Swine
  • Poultry
  • Ruminants
  • Aquaculture
  • Others